Your browser is no longer supported. Please, upgrade your browser.
Settings
CPIX Cumberland Pharmaceuticals Inc. daily Stock Chart
CPIX [NASD]
Cumberland Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.37 Insider Own36.90% Shs Outstand16.04M Perf Week-6.65%
Market Cap99.13M Forward P/E- EPS next Y-0.45 Insider Trans0.01% Shs Float9.11M Perf Month0.32%
Income-5.70M PEG- EPS next Q-0.16 Inst Own34.70% Short Float1.36% Perf Quarter8.42%
Sales38.90M P/S2.55 EPS this Y-772.70% Inst Trans-0.13% Short Ratio10.83 Perf Half Y-0.16%
Book/sh3.74 P/B1.65 EPS next Y-55.20% ROA-6.10% Target Price10.00 Perf Year-14.76%
Cash/sh2.98 P/C2.07 EPS next 5Y30.00% ROE-9.10% 52W Range5.06 - 7.60 Perf YTD-16.03%
Dividend- P/FCF- EPS past 5Y-30.00% ROI-11.30% 52W High-18.68% Beta0.48
Dividend %- Quick Ratio3.70 Sales past 5Y-3.40% Gross Margin82.90% 52W Low22.13% ATR0.45
Employees84 Current Ratio4.10 Sales Q/Q-24.10% Oper. Margin-15.50% RSI (14)49.64 Volatility4.93% 7.57%
OptionableNo Debt/Eq0.21 EPS Q/Q-125.30% Profit Margin-14.30% Rel Volume0.24 Prev Close6.38
ShortableYes LT Debt/Eq0.21 EarningsNov 13 AMC Payout- Avg Volume11.47K Price6.18
Recom2.50 SMA20-2.88% SMA504.57% SMA2000.91% Volume2,766 Change-3.13%
Nov-12-12Reiterated UBS Neutral $6.50 → $5
Feb-01-11Reiterated UBS Neutral $8 → $6.50
Dec-16-10Downgrade UBS Buy → Neutral $10 → $8
Aug-17-10Reiterated UBS Buy $11 → $10
Aug-17-10Reiterated Morgan Joseph Buy $15 → $10
Aug-17-10Downgrade Jefferies Buy → Hold $13 → $5.50
May-14-10Reiterated Morgan Joseph Buy $21 → $15
Dec-03-18 08:46AM  U.S. and China set to finalize a trade deal in the next three months Yahoo Finance
Nov-14-18 07:21AM  Edited Transcript of CPIX earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +12.00%
Nov-13-18 08:10PM  Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:01PM  Cumberland: 3Q Earnings Snapshot Associated Press
04:05PM  Cumberland Pharmaceuticals Reports Third Quarter 2018 Financial Results PR Newswire
Nov-07-18 04:05PM  Cumberland Pharmaceuticals To Announce Third Quarter 2018 Financial Results PR Newswire
Nov-06-18 02:23PM  Nashville pharma company pays $25M for drug brand American City Business Journals +16.01%
08:30AM  Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals PR Newswire
08:30AM  Cumberland Pharmaceuticals To Acquire VIBATIV® PR Newswire
Sep-27-18 03:27PM  The Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Ownership Structure Could Be Important Simply Wall St.
09:00AM  Newly Published Data Demonstrates Amifostine Delayed The Onset Of Acute Esophagitis For Small Cell Lung Cancer Patients PR Newswire
Sep-24-18 10:00AM  Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors PR Newswire
Sep-21-18 12:18PM  Exclusive: Music industry giant joins public health care company's board American City Business Journals
Aug-30-18 05:51AM  Edited Transcript of CPIX earnings conference call or presentation 14-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-14-18 04:57PM  Cumberland: 2Q Earnings Snapshot Associated Press
04:05PM  Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results PR Newswire
02:30PM  Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Aug-13-18 10:00AM  Cumberland Pharmaceuticals Appoints New Senior Executive PR Newswire
Aug-07-18 04:05PM  Cumberland Pharmaceuticals To Announce Second Quarter 2018 Financial Results PR Newswire
Jun-08-18 11:48AM  What You Must Know About Cumberland Pharmaceuticals Incs (NASDAQ:CPIX) Financial Strength Simply Wall St.
Jun-05-18 05:58PM  Edited Transcript of CPIX earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-08-18 05:52PM  Cumberland: 1Q Earnings Snapshot Associated Press
04:05PM  Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results PR Newswire
May-01-18 09:35AM  Cumberland Pharmaceuticals To Announce First Quarter 2018 Financial Results PR Newswire
Apr-09-18 09:00AM  Cumberland Pharmaceuticals Expands into Oncology Support PR Newswire
Mar-29-18 11:59AM  Why Cumberland Pharmaceuticals Incs (NASDAQ:CPIX) Ownership Structure Is Important Simply Wall St.
Mar-26-18 09:35AM  Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria PR Newswire
Mar-07-18 08:06PM  Edited Transcript of CPIX earnings conference call or presentation 6-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-06-18 06:11PM  Cumberland reports 4Q loss Associated Press
04:05PM  Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017 PR Newswire
12:00PM  Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Feb-27-18 04:05PM  Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2017 Financial Results PR Newswire
Feb-22-18 06:33PM  Why You Need To Look At This Factor Before Buying Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Simply Wall St.
Feb-15-18 03:19PM  Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) A Financially Sound Company? Simply Wall St.
Jan-30-18 09:35AM  Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients PR Newswire
Dec-26-17 10:45AM  The fastest-growing Nashville health care company of 2017 might surprise you American City Business Journals
Dec-25-17 04:15PM  Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO? Simply Wall St.
Dec-15-17 01:35PM  Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)? Simply Wall St.
Nov-24-17 08:25AM  Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare? Simply Wall St.
Nov-14-17 02:08PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 14, 2017 Capital Cube
Nov-13-17 05:51PM  Edited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
09:53AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017 Capital Cube
Nov-07-17 06:19PM  Cumberland reports 3Q loss Associated Press
04:05PM  Cumberland Pharmaceutical Reports 27% Revenue Growth In The Third Quarter PR Newswire
12:00PM  Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Oct-31-17 04:05PM  Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results PR Newswire
Oct-30-17 09:51AM  Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now? Simply Wall St.
Oct-27-17 06:01PM  Cumberland Pharmaceuticals Inc (CPIX): Time For A Financial Health Check Simply Wall St.
Oct-25-17 09:54AM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017 Capital Cube
Oct-09-17 11:25AM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 9, 2017 Capital Cube
Oct-06-17 09:09AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-25-17 08:00AM  Cumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology Intervention PR Newswire
Sep-13-17 06:07PM  What Are The Drivers Of Cumberland Pharmaceuticals Incs (CPIX) Risks? Simply Wall St.
Aug-17-17 06:11PM  Edited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 11:15PM  Cumberland reports 2Q loss Associated Press
04:05PM  Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter PR Newswire
11:10AM  Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 04:15PM  Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results PR Newswire
Jul-31-17 08:15AM  Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support PR Newswire
Jul-12-17 02:24PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017 Capital Cube
May-25-17 12:37PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : May 25, 2017 Capital Cube
May-24-17 10:13AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 Capital Cube
May-21-17 12:55PM  Edited Transcript of CPIX earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-15-17 05:26PM  Cumberland reports 1Q loss Associated Press
04:05PM  Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017 PR Newswire
02:30PM  Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call Accesswire
May-08-17 04:05PM  Cumberland Pharmaceuticals to Announce First Quarter 2017 Financial Results PR Newswire
Apr-26-17 08:00AM  New Kristalose® Growth Driver Established Through Co-Promotion Agreement PR Newswire
Mar-31-17 05:23PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Mar-27-17 04:15PM  Caldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use PR Newswire
Mar-22-17 05:28PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Stateme
02:34PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc. Accesswire
Mar-21-17 09:26AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube
09:26AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
Mar-17-17 09:37AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc. Business Wire
Mar-16-17 05:05PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
01:04PM  CUMBERLAND PHARMACEUTICALS INC Financials
Mar-15-17 01:13PM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Capital Cube
01:13PM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-13-17 06:06AM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
Mar-10-17 05:07PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
Mar-07-17 08:18PM  Edited Transcript of CPIX earnings conference call or presentation 7-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
06:26PM  Cumberland reports 4Q loss Associated Press
04:15PM  Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results PR Newswire
07:07AM  Q4 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
Feb-28-17 04:15PM  Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results PR Newswire
Feb-10-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Feb-07-17 08:15AM  Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics PR Newswire
Feb-03-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jan-30-17 08:15AM  U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case PR Newswire
Jan-20-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Jan-16-17 08:15AM  Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors PR Newswire
Jan-13-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jan-09-17 09:30AM  Cumberland Pharmaceuticals and Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect® PR Newswire
Dec-21-16 12:13PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : December 21, 2016
Nov-21-16 05:17PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Nov-17-16 08:15AM  Blog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market Accesswire
Nov-16-16 08:00AM  Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products PR Newswire
Nov-07-16 08:30AM  Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing PR Newswire
Nov-04-16 12:34PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 4, 2016
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, together with its subsidiaries, focuses on acquiring, developing, and commercializing branded prescription products for hospital acute care, gastroenterology, and oncology markets in the United States and internationally. Its marketed products include Acetadote (acetylcysteine) injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection for the treatment of pain and fever; Kristalose (lactulose) for the treatment of chronic and acute constipation; Vaprisol (conivaptan) injection for treating hyponatremia; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Ethyol (amifostine) for injection to treat oncology patients; and Totect Injection for the treatment of toxic effects. The company's product candidates in Phase II clinical trials comprise Hepatoren (ifetroban) injection for the treatment of hepatorenal syndrome; Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease; Vasculan (ifetroban) oral capsule for the treatment of systemic sclerosis; and Portaban for the treatment of portal hypertension. Its pre-approval products consist of RediTrexTM Methotrexate injection for treating active rheumatoid, juvenile idiopathic, and psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. Cumberland Pharmaceuticals Inc. has a strategic alliance with Clinigen Group plc and Nordic Group B.V. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bonner MichaelChief Financial OfficerAug 29Buy6.2410062418,454Aug 31 05:19 PM
Bonner MichaelChief Financial OfficerAug 28Buy5.923001,77618,354Aug 31 05:19 PM
Bonner MichaelChief Financial OfficerMay 17Buy6.124002,44818,054May 18 05:11 PM
Bonner MichaelChief Financial OfficerMar 19Buy6.723002,01615,997Mar 23 05:40 PM